TNF and ankylosing spondylitis: Data from a non-randomized case–control study in patients with inflammatory arthritis (RA, PsA and ankylosing spondylitis) showed that long-term use of anti-TNF-α therapy may result in a significant improvement in PWV compared to the non-treated group [44].